Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Media Articles Related to Meprobamate
Palliative care-led meetings do not reduce anxiety, depression of families of patients with chronic critical illness
Source: Anxiety / Stress News From Medical News Today [2016.07.06]
Among families of patients with chronic critical illness, the use of palliative care-led informational and emotional support meetings compared with usual care did not reduce anxiety or depression...
Low attention control in early adolescence is a genetic risk factor for anxiety disorders
Source: Anxiety / Stress News From Medical News Today [2016.06.22]
University of Texas at Arlington researchers have found that low attention control in early adolescence is related to a genetic risk factor for four different anxiety disorders.
Generalized Anxiety Disorder (GAD): Symptoms, Diagnosis & Treatment
Source: MedicineNet Intestinal Gas (Belching, Bloating, Flatulence) Specialty [2016.06.09]
Title: Generalized Anxiety Disorder (GAD): Symptoms, Diagnosis & Treatment
Created: 2/2/2012 12:00:00 AM
Last Editorial Review: 6/9/2016 12:00:00 AM
Anxiety disorders 'most common among women and young adults'
Source: Anxiety / Stress News From Medical News Today [2016.06.06]
A review of studies on anxiety disorders across the world has found that women, young adults, and people with other conditions are at the greatest risk.
Anxiety and depression linked to recurrence of inflammatory bowel disease
Source: Depression News From Medical News Today [2016.06.02]
Researchers at the University of York have discovered a link between a recurrence of inflammatory bowel disease (IBD) and anxiety and depression.
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
Reports of Suspected Meprobamate Side Effects
Toxicity TO Various Agents (28),
Respiratory Arrest (15),
Cardiac Arrest (15),
Accidental Death (14),
Drug Abuse (11),
Completed Suicide (11),
Multiple Drug Overdose Accidental (5),
Pulmonary Congestion (5),
Pulmonary Oedema (4), more >>
Page last updated: 2016-07-06